Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Feb 24, 2025 |
referred to consumer affairs and protection |
Assembly Bill A5852
2025-2026 Legislative Session
Sponsored By
STECK
Current Bill Status - In Assembly Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
co-Sponsors
Mary Beth Walsh
2025-A5852 (ACTIVE) - Details
- Current Committee:
- Assembly Consumer Affairs And Protection
- Law Section:
- General Business Law
- Laws Affected:
- Add §398-g, Gen Bus L
2025-A5852 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 5852 2025-2026 Regular Sessions I N A S S E M B L Y February 24, 2025 ___________ Introduced by M. of A. STECK, WALSH -- read once and referred to the Committee on Consumer Affairs and Protection AN ACT to amend the general business law, relating to regulating the sale of kratom products THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The general business law is amended by adding a new section 398-g to read as follows: § 398-G. KRATOM PACKAGE LABELING. 1. FOR THE PURPOSES OF THIS SECTION, THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEANINGS: (A) "KRATOM" MEANS BOTH MITRAGYNA SPECIOSA, A TREE NATIVE TO SOUTHEAST ASIA, AND THE PRODUCTS DERIVED FROM ITS LEAVES THAT ARE MARKETED AS HERBAL SUPPLEMENTS. (B) "ALL NATURAL" MEANS A PRODUCT THAT CONTAINS NO ARTIFICIAL INGREDI- ENTS OR ADDED COLORS AND IS MINIMALLY PROCESSED. 2. ON EACH PACKAGE OF ANY KRATOM PRODUCT SOLD OR DELIVERED BY A MANUFACTURER OR DISTRIBUTOR WITHIN THIS STATE ON OR AFTER JANUARY FIRST, TWO THOUSAND TWENTY-SIX, THERE SHALL BE PRINTED THEREON OR ATTACHED THERETO A WARNING OF SUCH PRODUCT'S LACK OF FEDERAL FOOD AND DRUG ADMIN- ISTRATION APPROVAL AND SUCH KRATOM PRODUCTS' KNOWN SIDE EFFECTS. SUCH WARNING SHALL BE IN A FONT NOT LESS THAN EIGHT-POINT TYPE AND IN A COLOR IN CONTRAST WITH THE PACKAGE CONTAINING SUCH KRATOM PRODUCT, AND SHALL CONTAIN THE FOLLOWING STATEMENT: "WARNING THIS PRODUCT HAS NOT BEEN APPROVED BY THE FDA. SIDE EFFECTS MAY INCLUDE NAUSEA, AGITATION, HALLUCINATIONS, DIFFICULTY BREATHING, LIVER DAMAGE, AND DEATH" 3. NO KRATOM PRODUCT SHALL BE ADVERTISED AS NOR SHALL THE PACKAGING OF SUCH KRATOM PRODUCT SUGGEST, STATE, OR IMPLY THAT SUCH KRATOM PRODUCT IS ALL NATURAL. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD09239-01-5 A. 5852 2
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.